# S0106A, Biomarkers in Samples From Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Cytarabine-Based Chemotherapy

> **NCT01360125** · — · COMPLETED · sponsor: **SWOG Cancer Research Network** · enrollment: 310 (actual)

## Conditions studied

- Leukemia

## Interventions

- **GENETIC:** proteomic profiling
- **OTHER:** flow cytometry
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01360125
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 310 (ACTUAL)
- **Last updated:** 2016-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01360125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01360125, "S0106A, Biomarkers in Samples From Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Cytarabine-Based Chemotherapy". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01360125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*